Ixekizumab leads to greater improvement in itch severity in psoriasis – Healio
Ixekizumab leads to greater improvement in itch severity in psoriasisHealioIxekizumab Impact on Itch Severity Compared to Etanercept and Placebo: Results from Undercover-2, a Phase 3 Trial in Patients with Plaque Psoriasis. Presented at: 23rd World Congress of Dermatology; June 8-13, 2015; Vancouver, British Columbia.and more »
[monetize id=”1″] [monetize id=”2″]
Humira Commercial – Lakehouse
Greece, U.S. Home Sales, Iran, NATO, Golf: Week Ahead June 20-27 – Bloomberg
BloombergGreece, U.S. Home Sales, Iran, NATO, Golf: Week Ahead June 20-27Bloomberg-Eli Lilly & Co. Hosts a webcast to discuss Phase III trial studies of its experimental ixekizumab drug for the treatment of moderate-to-severe plaque psoriasis. 10:00 EDT. -Bernstein Global Future of Media & Telecom Summit. TiVo Inc., Nielsen NV and …
